Simvastatin and clarithromycin — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Ask the prescriber to review the macrolide or temporarily withhold simvastatin
Clarithromycin inhibits CYP3A4 and can increase simvastatin exposure, raising myopathy and rhabdomyolysis risk. CKD and previous muscle symptoms increase clinical concern. The prescriber should consider an alternative antibiotic or advise temporary statin interruption as appropriate. Changing administration time will not remove the metabolic interaction.
Reference: BNF